{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:41:47Z","timestamp":1781196107770,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":170,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["L30CA274749"],"award-info":[{"award-number":["L30CA274749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["K08DK119466"],"award-info":[{"award-number":["K08DK119466"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.lrr.2023.100377","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:10:18Z","timestamp":1687295418000},"page":"100377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report"],"prefix":"10.1016","volume":"20","author":[{"given":"Anna-Eve","family":"Turcotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie S.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lrr.2023.100377_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajh.20109","article-title":"Membranous glomerulonephritis in chronic lymphocytic leukemia","volume":"76","author":"Ziakas","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.lrr.2023.100377_bib0002","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2015.128793","article-title":"Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the mayo clinic experience","volume":"100","author":"Strati","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.lrr.2023.100377_bib0003","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","article-title":"Treatment of chronic lymphocytic leukemia","volume":"383","author":"Burger","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lrr.2023.100377_bib0004","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000013626","article-title":"Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia","volume":"20","author":"Yahata","year":"2000","journal-title":"Am. J. Nephrol."},{"issue":"25","key":"10.1016\/j.lrr.2023.100377_bib0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2023.100377_bib0006","first-page":"1224","article-title":"Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome","volume":"85","author":"Abdel-Raheem","year":"2000","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.lrr.2023.100377_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archinte.1986.00360130167023","article-title":"A review of nephrotic syndrome associated with chronic lymphocytic leukemia","volume":"146","author":"Seney","year":"1986","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.lrr.2023.100377_bib0008","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.humpath.2010.09.009","article-title":"Alpers CE. Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms","volume":"42","author":"Kowalewska","year":"2011","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.lrr.2023.100377_bib0009","first-page":"107","article-title":"Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study","volume":"31","author":"Touchard","year":"1989","journal-title":"Clin. Nephrol."},{"issue":"3","key":"10.1016\/j.lrr.2023.100377_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.kint.2020.08.038","article-title":"Hundemer GL. The case | Nephrotic syndrome in a patient with chronic lymphocytic leukemia","volume":"99","author":"Ahmed","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lrr.2023.100377_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.1992.270","article-title":"Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas","volume":"42","author":"Moulin","year":"1992","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.lrr.2023.100377_bib0012","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ckj\/sfy026","article-title":"Renal involvement in chronic lymphocytic leukemia","volume":"11","author":"Wanchoo","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.lrr.2023.100377_bib0013","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fimmu.2019.01809","article-title":"Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"issue":"174","key":"10.1016\/j.lrr.2023.100377_bib0014","first-page":"207","article-title":"Membranous nephropathy. Long-term follow-up and association with neoplasia","volume":"44","author":"Row","year":"1975","journal-title":"Q. J. Med."},{"issue":"7","key":"10.1016\/j.lrr.2023.100377_bib0015","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/0002-9343(76)90575-1","article-title":"The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature","volume":"60","author":"Gagliano","year":"1976","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.lrr.2023.100377_bib0016","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ekir.2017.07.008","article-title":"Membranous glomerulopathy with light chain-restricted deposits: a clinicopathological analysis of 28 cases","volume":"2","author":"Best Rocha","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"2","key":"10.1016\/j.lrr.2023.100377_bib0017","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1016\/S0272-6386(99)70329-X","article-title":"Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine","volume":"33","author":"Butty","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.lrr.2023.100377_bib0018","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.10611110","article-title":"Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab","volume":"6","author":"Guiard","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lrr.2023.100377_bib0019","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/0886022X.2012.743912","article-title":"Fludarabine in chronic lymphocytic leukemia with membranous nephropathy","volume":"35","author":"Rocca","year":"2013","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.lrr.2023.100377_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.1977.47","article-title":"Glomerulopathies of neoplasia","volume":"11","author":"Eagen","year":"1977","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lrr.2023.100377_bib0021","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3324\/haematol.2010.036152","article-title":"Chronic lymphocytic leukemia and autoimmunity: a systematic review","volume":"96","author":"Hodgson","year":"2011","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.lrr.2023.100377_bib0022","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood.2021014488","article-title":"Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort","volume":"139","author":"Tam","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2023.100377_bib0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood.2021014960","article-title":"Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial","volume":"140","author":"Shanafelt","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.lrr.2023.100377_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102468","article-title":"Current treatment options in CLL","volume":"13","author":"Bewarder","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"5937","key":"10.1016\/j.lrr.2023.100377_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bmj.4.5937.164","article-title":"Letter: nephrotic syndrome in chronic lymphatic leukaemia","volume":"4","author":"Cameron","year":"1974","journal-title":"Br. Med. J."},{"issue":"12","key":"10.1016\/j.lrr.2023.100377_bib0026","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19831215)52:12<2253::AID-CNCR2820521215>3.0.CO;2-L","article-title":"Membranous nephropathy associated with an unusual phenotype of chronic lymphocytic leukemia","volume":"52","author":"White","year":"1983","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.lrr.2023.100377_bib0027","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000188915","article-title":"Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia","volume":"72","author":"Eisterer","year":"1996","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.lrr.2023.100377_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients","volume":"67","author":"Da'as","year":"2001","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.lrr.2023.100377_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archinte.1968.03640010073012","article-title":"Chronic lymphocytic leukemia, Hodgkin's disease, and the nephrotic syndrome","volume":"121","author":"Brodovsky","year":"1968","journal-title":"Arch. Intern. Med."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:49Z","timestamp":1761959329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048923000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"alternative-id":["S2213048923000171"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100377","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100377"}}